These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2172802)

  • 21. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of cat expression by anti-androgens.
    Fuhrmann U; Bengtson C; Repenthin G; Schillinger E
    J Steroid Biochem Mol Biol; 1992 Sep; 42(8):787-93. PubMed ID: 1326316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
    Whitacre DC; Karnas KJ; Miesfeld RL
    Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat.
    Yarbrough WG; Quarmby VE; Simental JA; Joseph DR; Sar M; Lubahn DB; Olsen KL; French FS; Wilson EM
    J Biol Chem; 1990 May; 265(15):8893-900. PubMed ID: 2341409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a functional androgen-response element in the exon 1-coding sequence of the cystatin-related protein gene crp2.
    Devos A; Claessens F; Alen P; Winderickx J; Heyns W; Rombauts W; Peeters B
    Mol Endocrinol; 1997 Jul; 11(8):1033-43. PubMed ID: 9212051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced androgen receptor gene expression with first exon CAG repeat expansion.
    Choong CS; Kemppainen JA; Zhou ZX; Wilson EM
    Mol Endocrinol; 1996 Dec; 10(12):1527-35. PubMed ID: 8961263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-binding of androgen receptor overexpressed in mammalian cells.
    von Krempelhuber A; Müller F; Fuhrmann U
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):511-6. PubMed ID: 8180112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phorbol ester causes ligand-independent activation of the androgen receptor.
    Darne C; Veyssiere G; Jean C
    Eur J Biochem; 1998 Sep; 256(3):541-9. PubMed ID: 9780230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.
    Zhang J; Thomas TZ; Kasper S; Matusik RJ
    Endocrinology; 2000 Dec; 141(12):4698-710. PubMed ID: 11108285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays.
    Gao T; Brantley K; Bolu E; McPhaul MJ
    Mol Endocrinol; 1999 Oct; 13(10):1645-56. PubMed ID: 10517667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional activation by TR3 receptor, a member of the steroid receptor superfamily.
    Kokontis J; Liao S; Chang C
    Receptor; 1991; 1(4):261-70. PubMed ID: 1843211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
    Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
    Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase.
    Jeong BC; Hong CY; Chattopadhyay S; Park JH; Gong EY; Kim HJ; Chun SY; Lee K
    Mol Endocrinol; 2004 Jan; 18(1):13-25. PubMed ID: 14576337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of a DNA-binding domain replacement method for the detection of a potential TR3 orphan receptor response element in the mouse mammary tumor virus long terminal repeat.
    Lee HJ; Kokontis J; Wang KC; Chang C
    Biochem Biophys Res Commun; 1993 Jul; 194(1):97-103. PubMed ID: 8392847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
    Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
    Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.